Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy

Since the incidence of mucosal melanoma is higher in the Japanese population compared to Caucasians, and since mucosal melanoma possesses a lower mutation burden compared to cutaneous melanoma, the efficacy of anti-PD1 antibody (Ab) monotherapy for mucosal melanoma is limited. Therefore, other targe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Case Rep Oncol
Päätekijät: Fujimura, Taku, Kambayashi, Yumi, Ohuchi, Kentaro, Amagai, Ryo, Sato, Yota, Tanita, Kayo, Hashimoto, Akira, Aiba, Setsuya
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2020
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154272/
https://ncbi.nlm.nih.gov/pubmed/32308589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000506327
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia